Maintaining a normalized sense of quality of life when suffering from a life-long disease or disability is critically important; thus, understanding the direct and indirect effects of the mediating effect of barriers to successful employment onto quality of life, depression and anxiety, supplements the existing research understanding of NF1 and how individuals experience the disease [27–29]. The gene discussed is NF1; the disease is depressive symptom measurement.